TY - JOUR JO - EuroIntervention TI - Bivalirudin infusion to reduce ventricular infarction: the open-label, randomised Bivalirudin Infusion for Ventricular InfArction Limitation (BIVAL) study AB - <p class="text-1er-paragraph"><span class="abstracts-titres">Aims:</span> The aim of the study was to investigate whether bivalirudin versus unfractionated heparin (UFH) reduces infarct size (IS) for primary percutaneous coronary intervention (PPCI) in la AU - van Geuns M. Robert-Jan AU - Sideris Georgios AU - van Royen Niels AU - El Mahmoud Rami AU - Diletti Roberto AU - Sollier Claire Bal dit AU - Garot Jérome AU - Van Der Hoeven Nina W. AU - Cortese Bernardo AU - Ding Li AU - Lechthaler Ilknur AU - Deliargyris Efthymios N. AU - Anthopoulos Prodromos AU - Drouet Ludovic VL - 13 IS - 5 Y1 - 04/08/2017 Y1 - 2017 DOI - 10.4244/EIJ-D-17-00307 SP - e540 EP - e548 KW - adjunctive pharmacology KW - clinical trials KW - magnetic resonance imaging (mri) KW - other imaging modalities KW - st-elevation myocardial infarction (stemi) PB - Europa Digital & Publishing SE - CORONARY INTERVENTIONS UR - https://eurointervention.pcronline.com/article/bivalirudin-infusion-to-reduce-ventricular-infarction-the-open-label-randomised-bivalirudin-infusion-for-ventricular-infarction-limitation-bival-study SN - 1774-024X ER -